tiprankstipranks
Creo Medical Expands Lung Cancer Treatment Sites
Company Announcements

Creo Medical Expands Lung Cancer Treatment Sites

Creo Medical (GB:CREO) has released an update.

Pick the best stocks and maximize your portfolio:

Creo Medical Group plc has amended its collaboration agreement with Intuitive Surgical Inc. to increase the number of UK and European sites performing combined lung cancer diagnosis and ablation procedures using Creo’s MicroBlate Flex device with Intuitive’s robotic system. The expansion aims to collect clinical evidence and advance commercialization, with initial procedures at new sites expected to begin within the year. Creo’s CEO highlights the potential of this single-anesthetic event for early lesion diagnosis and treatment to improve lung cancer survivability.

For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskCreo Medical Chairman Increases Stake with Significant Share Purchase
TipRanks UK Auto-Generated NewsdeskCreo Medical Reports Share Capital and Voting Rights
TipRanks UK Auto-Generated NewsdeskCreo Medical CFO’s Strategic Share Transaction
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App